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Abstract 
Background: Poly‑lactic acid nanoparticles (PLA‑NP) are a type of polymeric NP, frequently used as nanomedicines, 
which have advantages over metallic NP such as the ability to maintain therapeutic drug levels for sustained periods of 
time. Despite PLA‑NP being considered biocompatible, data concerning alterations in cellular physiology are scarce.
Methods: We conducted an extensive evaluation of PLA‑NP biocompatibility in human lung epithelial A549 cells 
using high throughput screening and more complex methodologies. These included measurements of cytotoxicity, 
cell viability, immunomodulatory potential, and effects upon the cells’ proteome. We used non‑ and green‑fluorescent 
PLA‑NP with 63 and 66 nm diameters, respectively. Cells were exposed with concentrations of 2, 20, 100 and 200 µg/
mL, for 24, 48 and 72 h, in most experiments. Moreover, possible endocytic mechanisms of internalization of PLA‑NP 
were investigated, such as those involving caveolae, lipid rafts, macropinocytosis and clathrin‑coated pits.
Results: Cell viability and proliferation were not altered in response to PLA‑NP. Multiplex analysis of secreted media‑
tors revealed a low‑level reduction of IL‑12p70 and vascular epidermal growth factor (VEGF) in response to PLA‑NP, 
while all other mediators assessed were unaffected. However, changes to the cells’ proteome were observed in 
response to PLA‑NP, and, additionally, the cellular stress marker miR155 was found to reduce. In dual exposures of 
staurosporine (STS) with PLA‑NP, PLA‑NP enhanced susceptibility to STS‑induced cell death. Finally, PLA‑NP were rap‑
idly internalized in association with clathrin‑coated pits, and, to a lesser extent, with lipid rafts.
Conclusions: These data demonstrate that PLA‑NP are internalized and, in general, tolerated by A549 cells, with no 
cytotoxicity and no secretion of pro‑inflammatory mediators. However, PLA‑NP exposure may induce modification of 
biological functions of A549 cells, which should be considered when designing drug delivery systems. Moreover, the 
pathways of PLA‑NP internalization we detected could contribute to the improvement of selective uptake strategies.
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Background
The development and improvement of nanostruc-
tured materials with biocompatible characteristics are 
important objectives in the field of nanomedicine. Vari-
ous NP have been developed for drug delivery, with gold 
nanoparticles (Au-NP) being the most used [18]. The 
advantages of Au-NP include the possibility of surface 
functionalization with a wide range of molecules and 
low or no cytotoxicity [54]. However, recent studies have 
performed extensive evaluation of Au-NP in several cell 
lines and have demonstrated their potential to induce 
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cytotoxicity [9, 14, 15], endoplasmic reticulum stress, 
cleavage of cytoskeletal proteins [50], and susceptibil-
ity to cell death by apoptosis [37]. Au-NP demonstrated 
a slow clearance in mouse organs including muscle, 
liver, spleen, and kidney even 3  months post intrave-
nous administration [77], and similar observations were 
made for rats [22]. This accumulation and slow clearance 
is a concern, as cells of the immune system can migrate 
into organs of the reticuloendothelial system, as well as 
resident immune cells, typically macrophages, may inter-
nalize Au-NP and release pro-inflammatory mediators, 
affecting the body homeostasis [56, 77]. Differences in 
the toxicity of Au-NP observed in existing studies could 
be in part a consequence of different physicochemical 
properties or due to different experimental designs when 
assessing their toxicity (e.g. differences in cell type, con-
centration, time point, assay sensitivity, NP shape and 
size, etc.) [51, 52, 60]. Thus, efforts are made to develop 
not only biocompatible, but also biodegradable NP.
Biodegradable and biocompatible nanocarriers for 
drug delivery have been prepared from different poly-
mers and protocols in order to reduce cytotoxicity [43], 
which, in part, may be attributed to metal components 
of existing therapies or NP accumulation in organs and 
poor clearance [38]. Poly-lactic acid NP (PLA-NP) are 
a type of polymeric NP with potential applications in 
nanomedicine as carriers of drugs, proteins and genes 
[29, 75]. PLA-NP offers several benefits, such as sustain-
able therapeutic drug release over prolonged periods, 
due to their polymer matrix allowing the control of drug 
release kinetics [42]. In fact, the Food and Drug Admin-
istration (FDA) have approved the use of biodegradable 
materials, including PLA-NP, in humans [73]. Previous 
studies have evaluated the cytotoxic potential of PLA-NP 
in different cell types, such as CHO-K1 [46], HEK293 [6], 
retinal pigment epithelium [7], and MCF-7 and SK-BR-3 
breast cancer cell lineages [43]. These studies concluded 
that PLA-NP were non-cytotoxic; these conclusions were 
based on the assessment of cell viability through meas-
urements of mitochondrial activity, while other cellular 
stress parameters were not considered. Thus, the objec-
tive of the present study was to perform an extensive and 
thorough evaluation of PLA-NP effects, including cel-
lular viability, analysis of intracellular ATP content, pro-
liferation determined by electrical impedance, cytokine 
release, mRNA, and miRNA levels related to cell toxic-
ity, stress and inflammation. In addition, we performed a 
proteomics approach aiming at investigating the compo-
sition of intracellular proteins that could be altered, infer-
ring changes in biological function. We used the human 
A549 lung epithelial cell line, since the respiratory tract is 
one of the most important routes of administration and 
fast absorption of nanomedicine delivery systems. The 
inhalation route displays advantages such as avoidance 
of first-pass metabolism, fewer systemic side effects and 
circumvents the necessity for using needles. Previously, 
it has been shown that the cytotoxicity of polymeric NP 
loaded with cancer chemotherapeutics against A549 cells 
was greater compared to free drug, reinforcing the use-
fulness of polymeric NP as potential nanocarriers in lung 
cancer therapy. This was further reiterated when poly-
meric NP were administered to rats via inhalation, and 
higher drug concentrations were observed in the lung 
compared to plasma [2, 69].
In addition, this study investigated endocytic mecha-
nisms related to PLA-NP uptake. Some well-char-
acterized mechanisms of uptake pathways include 
endocytosis mediated by lipid rafts, caveolae, macropino-
cytosis and clathrin-coated pits. Lipid rafts are microdo-
mains enriched with cholesterol and sphingolipids, and 
are involved in many functions such as compartmentali-
zation of proteins related to intracellular signaling path-
ways, cellular communication, and endocytosis through 
still unknown mechanisms. Caveolae are structures simi-
lar to lipid rafts but formed by cell membrane invagina-
tions that require caveolin proteins for their formation 
[17]. Macropinocytosis is an endocytic pathway for large 
contents of extracellular fluid that is dependent on cell 
membrane ruffling, and formation of macropinosomes. 
Clathrin-mediated endocytosis initiates from a cellular 
signal that promotes membrane invagination via clath-
rin-coated pit formation and vesicle release to the cyto-
sol in a dynamin-dependent manner. Once in the cytosol, 
the clathrin coat is lost and uncoated vesicles fuse, result-
ing in early endosomes [20]. The interaction between NP 
and cell membranes is dependent on NP physicochemical 
characteristics and cell membrane properties, which in 
turn influences their intracellular trafficking and accumu-
lation into organelles [1]. Recently, a study demonstrated 
that CCR5-targeted caveolin-1-functionalized NP were 
more efficiently internalized by non-phagocytic CD4+ 
T cells, when compared to untargeted NP, suggesting a 
potential strategy for drug delivery [25]. Therefore, the 
understanding of how to drive PLA-NP to target cell and 
the uptake mechanisms involved in its internalization 
through eukaryotic cell membranes are critical to design 
and develop selective strategies for reducing side effects 
and/or promoting an increase in active drug levels.
Methods
Nanoparticles and chemicals
Spherical monodispersed non- and green-fluorescent, 
Coumarin-6, PLA-NP (1.05  ×  1013  particles/mL) were 
used [36]. Non-fluorescent NP were used in assays with 
light detection-dependent endpoints. Both NP were 
acquired from Institute of Biology and Chemistry of 
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Proteins (IBCP), Lyon, France. RPMI 1640 medium sup-
plemented with l-glutamine and fetal bovine serum 
(FBS) were purchased from Gibco BRL (Grand Island, 
NY, USA). Genistein, methyl-β-cyclodextrin (MCD) and 
amiloride hydrochloride hydrate were acquired from 
Sigma Chem. Co. (Saint Louis, MO, USA). Pitstop 2 was 
purchased from Abcam Biochemicals (Cambridge, UK).
Nanoparticle characterization
The hydrodynamic diameter of green fluorescent (Cou-
marin-6, ex/em:444/505 nm) or non-fluorescent PLA-NP 
was determined by dynamic light scattering (DLS), after 
dilution in water. PLA-NP were also assessed in cell cul-
ture medium, at the same concentrations that were used 
in cell experiments. RPMI medium without FBS was used 
to dilute PLA-NP for TEM analysis. Particle suspensions 
were applied to TEM grids and left to dry prior to imag-
ing using a LEO 912 AB Omega transmission electron 
microscope (Zeiss, Oberkochen) operated at 120 kV with 
a LaB6 cathode.
For analysis of NP hydrodynamic diameter and polydis-
persity index, PLA-NP were diluted in complete medium 
and incubated in cell culture flasks without cells follow-
ing the same criteria as cell experiments. Then, 1 mL of 
sample was transferred to an appropriate cuvette for sub-
sequent analysis by DLS and zeta potential in the Mal-
vern Zetasizer Nano ZS apparatus (Malvern Instruments 
Ltd, Worcestershire, UK).
Cell culture
A549 epithelial cells were mycoplasma-free (MycoAlert 
Mycoplasma Detection Kit-Lonza, Bazel, Switzerland), 
used for no more than 20 passages, and were seeded for 
experiments at 1.5  ×  104  cells/cm2. Cells were main-
tained in complete RPMI medium (10% FBS) according 
to ATCC Laboratories. PLA-NP were previously diluted 
at room temperature (RT), vortexed for 1 min and added 
to the cells at different concentrations (2, 20, 100 and 
200 µg/mL, or 3.36 × 109, 3.36 × 1010, 1.68 × 1011 and 
3.36  ×  101  particles/mL, respectively) 24  h after cell 
seeding. After 24, 48 and/or 72 h of treatment, superna-
tants were collected and cells were used in experimental 
procedures. For the endocytosis inhibitors used in the 
uptake study, concentration- and time-dependent tox-
icity assessment was performed for each inhibitor and 
sublethal conditions were used in final experiments. It is 
important to highlight that each cell type has a different 
tolerance to chemicals and therefore subtoxic concen-
trations should always be determined in a case-by-case 
fashion. For the A549 cells used here, the subtoxic con-
centrations used were 200  µM genistein, 2  mM MCD, 
1.5 mM amiloride, and 12.5 µM pitstop 2 [4, 8, 28, 35]. 
All inhibitors were applied to cells for 40 min, except for 
pitstop 2, which was applied for only 10 min. After incu-
bation with endocytosis inhibitors, the cells were washed 
and further incubated with 20  µg/mL PLA-NP for 1 or 
4  h. In the cytotoxicity and viability assays, the positive 
control for cell death was performed by incubation with 
1% Triton X-100 (TX-100) for 20 min. Absorbance, fluo-
rescence and luminescence were measured in a Tecan 
Infinite 200PRO microplate reader. Intrinsic NP inter-
ference was measured for each experiment, using the 
respective assay reagents and excluding cells; these values 
were subtracted from experimental groups.
MTT assay
After PLA-NP exposure, cells were washed twice 
with PBS and 100 µL of complete medium containing 
0.15  mg/mL MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-di-
phenyl-2H-tetrazolium bromide, Sigma Chem. Co., Saint 
Louis, MO, USA) was added. After 3  h, supernatants 
were discarded, cells washed twice with PBS, and sam-
ples homogenized with 100 µL DMSO. Absorbance was 
measured at 480 nm with reference readings at 690 nm.
Intracellular ATP (adenosine triphosphate) analysis
Cells were lysed with CelLytic M lysis buffer containing 
1% protease inhibitor cocktail, according to the manu-
facturer’s recommendations (Molecular Probes, Eugene, 
OR, USA). Samples were transferred to flat-black 96 
multi-well plates followed by the addition of the stand-
ard reaction solution containing recombinant firefly 
luciferase and its substrate d-luciferin (ATP Determina-
tion Kit, Molecular Probes, Eugene, OR, USA). Plates 
were incubated for 10 min at 28 °C and luminescence was 
determined.
Lactate dehydrogenase (LDH) release assay
LDH release was determined using the colorimetric 
CytoTox 96 Cytotoxicity Assay kit (Promega, Madison, 
WI, USA). A positive control was performed by treating 
cells with 1% TX-100 for 20  min. After PLA-NP treat-
ments, 30  µL of cell supernatants were transferred to 
new 96-well plates followed by the addition of 30 µL of 
substrate solution. After 20 min of incubation in the dark 
at RT, 30 µL of stop solution was added to each sample. 
Color development was proportional to the number of 
cells with disruption of plasma membrane. Absorbance 
was measured at 490 nm.
Real‑time electrical impedance cell monitoring
Cells were seeded in 96-well E-Plate View xCELLigence 
RTCA SP system containing gold microelectrodes on 
well bottoms (ACEA Biosciences, San Diego, CA, USA). 
This label-free methodology is sensitive enough to meas-
ure slight differences of cell response under a wide range 
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of stimuli. After cell seeding for 24 h, the instrument was 
programmed to monitor cell proliferation and cytotox-
icity each hour during 96  h, through electrical imped-
ance analysis. PLA-NP were added after the first 24  h 
growth and cells were monitored for a further 72 h. Cell 
impedance is represented by cell index (CI) =  (Zi − Z0) 
[Ohm]/15[Ohm], where Z0 is background resistance and 
Zi is resistance at an individual time point. Normalized 
cell index was determined as cell index at a specific time 
point (CIti) divided by cell index at normalization time 
point (CInml_time).
Proteomics assay
Cells were treated with 20 µg/mL PLA-NP for 24 h, pro-
tein was extracted using a lysis buffer (CelLytic M) with 
1% protease inhibitor cocktail (Sigma, Saint Louis, MO, 
USA). Soluble proteins were recovered and quantified by 
2-D Quant kit (GE Healthcare, USA) resulting in an aver-
age of 3 µg/µl. Then, 50 ug of each sample was processed 
for mass spectrometry analysis. Sequencing grade por-
cine trypsin (Promega, USA) was used to digest proteins 
that were previously reduced and alkylated by incubation 
with 10 mM dithiothreitol (DTT) and 55 mM iodoaceta-
mide (IAA), respectively. Tryptic peptides were analyzed 
by liquid chromatography tandem mass spectrometry 
(LC–MS/MS) using a nanoACQUITY UPLC system cou-
pled to a Synapt G1 High Definition Mass Spectrometer 
(Waters, USA). Nanoflow ESI source was applied with 
a lock spray source for lock mass measurements dur-
ing all chromatographic runs. Digested proteins were 
desalted using a Trap Symmetry C18 column (Waters, 
USA). Mixture of trapped peptides was eluted with a 
water/ACN 0.1% formic acid gradient through a Symme-
try C18 (150  µm) capillary column. Data were acquired 
in expression mass spectrometry mode (MSE). Samples 
were initially run once in sequence for normalization by 
ion counting method. Then, normalized samples were 
analyzed in triplicates by mass spectrometry. The LC–
MS/MS data were processed by ProteinLynx 2.0 software 
(Waters, USA) to a search against a protein human data-
base from UniProt Protein Knowledgebase (http://www.
uniprot.org/uniprot/?query=Human&sort=score).
Quantitative real‑time polymerase chain reaction (qPCR)
Total RNA was extracted from A549 cells treated for 
72 h with 20 µg/mL PLA-NPs using miRNeasy mini kit 
(Qiagen, USA) according to manufacturer’s instruc-
tions. The amount and purity of total RNA were evalu-
ated with a UV spectrophotometer (NanoDrop 2000, 
Thermo Fisher Scientific Inc, MA, USA), by A260/280 
and 260/230 ratios, considering the cut-off values equal 
or greater than 2.0 and 1.8, respectively. The integrity of 
the RNA extracted was evaluated in bleach gel stained 
with gel red (Biotium, CA, USA). The material was stored 
at −80  °C until ready for gene expression analysis. For 
TP53, PCNA and PPARγ mRNA expression analysis, all 
the reagents were purchased from Applied Biosystems, 
USA. The qPCR was performed using the AgPath-ID 
one-step RT-PCR kit. Briefly, purified RNA was reverse 
transcribed and amplified. Individual mRNAs were quan-
tified with the 7500 Real-Time PCR System (Applied 
Biosystems, USA) using TaqMan Gene Expression 
Assays (TP53-Hs01034249_m1, PCNA- Hs00427214_g1, 
PPARγ-Hs01115513_m1). The reference genes CASC3 
(cancer susceptibility candidate gene 3) and RPL10 (that 
encodes the 60S ribosomal protein L10) were used as 
internal controls. Thermal cycling comprised of a 10 min 
RT step at 45  °C, and a 10  min initial PCR activation 
step at 95 °C (AmpliTaq Gold activation), followed by 40 
cycles of 95 °C for 15 s and 60 °C for 45 s. For micro-RNA 
(miRNA) analysis, the cDNA synthesis was performed 
using TaqMan MicroRNA Reverse Transcription Kit 
(Applied Biosystems, USA). Custom PCR Array plates 
containing specific primers were used to detect miRNAs 
that play a role in inflammation and cell death processes: 
let-7a, miR21, miR125b, miR155. miR17-5p was selected 
as internal control. The cycle parameters comprised of 
10 min at 95 °C, followed by 40 cycles of 15 s at 95 °C and 
1 min at 60 °C, according to the manufacturer. The 2−ΔΔCt 
method was performed for comparing relative fold 
expression differences.
Multiplex analysis of secreted products
Determination of proteins secreted by A549 cells upon 
exposure of PLA-NP was carried out, using Luminex 
xMAP magnetic technology, for the following analytes: 
IL-1β, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, 
IL-10, IL-12 (p70), IL-13, IL-15, IL-17, eotaxin, bFGF, 
GCSF, GM-CSF, IFN-γ, IP-10, MCP-1 (MCAF), MIP-1α, 
MIP-1β, PDGF-BB, RANTES, TNFα, VEGF. The posi-
tive control used was 20 ng/mL TNFα. The assays were 
performed following the manufacturer’s recommenda-
tions. In brief, after calibration and validation of Bio-Plex 
Magpix (Biorad Laboratories Inc., Hercules, CA, USA), 
reagent reconstitution and standard curve preparation, 
magnetic beads were added to each well of the assay 
plate. Each step was preceded by washing steps using an 
automated Bio-Plex Pro wash station (Biorad Labora-
tories Inc., Hercules, CA, USA). Beads were added fol-
lowed by supernatant samples, standard and controls 
and incubated in the dark for 1  h at 350  rpm. Samples 
were incubated with detection antibodies, using the same 
incubation parameters. Streptavidin-PE was added and 
incubated in the dark for 30 min at 350 rpm. Finally, mag-
netic beads were resuspended in assay buffer, agitated 
at 1200  rpm for 30  s and read in the Bio-Plex Magpix 
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apparatus. Assay interference was controlled by incuba-
tion of the PLA-NP with a standard series of IL-8 deter-
mined by ELISA and of IL-12 and VEGF determined by 
Magpix technology suggesting that PLA-NP do not bind 
the secreted products (data not shown).
Caspases‑3/7 assay
Cells were previously incubated with non-fluorescent 
PLA-NP in a black flat-bottom 96 multi-well plate for 
72  h at 37  °C, followed by PBS washing and incubation 
with 100 nM staurosporine (STS) for 24 h at 37 °C. Posi-
tive controls were performed by incubating cells with 
STS only. The Apo-ONE Homogeneous Caspases-3/7 
(Promega, Madison, WI, USA) assay was performed fol-
lowing manufacturer recommendations. Fluorescence 
intensity was quantified using 485/528  nm excitation/
emission in a Tecan Infinite 200PRO microplate reader.
Fluorescent confocal analysis
After exposure to PLA-NP, cells were washed with PBS 
and fixed with 4% formaldehyde for 15 min at room tem-
perature. Cells were permeabilized and blocked with 1% 
bovine serum albumin for 1 h. F-actin was stained using 
rhodamine-labelled phalloidin (1:100 dilution of stock, 
6.6 µM in 0.1% BSA) for 1 h at RT and slides mounted with 
Prolong Gold Antifade reagent with DAPI (4′,6-diamid-
ino-2-phenylindole, both from Molecular Probes, Eugene, 
OR, USA). For lipid raft staining, the Alexa Fluor 594-cou-
pled cholera toxin subunit B (CTX, 1  µg/mL, Molecular 
Probes) was used, a lipid raft marker which binds to gan-
glioside GM1. A549 cells were incubated for 10 min at 4 °C 
with CTX, followed by PLA-NP treatment for 60  min at 
37 °C and fixed as previously described. Confocal imaging 
was performed with a Leica TCS SP5 confocal laser scan-
ning microscope (Mannheim, Germany) coupled to a DMI 
6000B inverted microscope and a 63× water immersion 
objective with an 1.2 numerical aperture. For the excita-
tion of PLA-NP fluorescence, the 488 nm line of the Argon 
laser was used and the emitted light was detected at 500–
537 nm range. DAPI was excited at 405 nm (diode laser) 
and detected between 430 and 472  nm. Rhodamine and 
Alexa Fluor 594 were excited at 561  nm (diode pumped 
solid-state laser) and the detection window was 589-
679  nm. The adjustment of gain settings was performed 
on untreated control samples and Z-stack images were 
acquired with a step size between 130 and 210 nm.
Flow cytometry
Endocytosis inhibitors were used and PLA-NP treat-
ments were performed as previously described [4, 8, 28, 
35]. After PLA-NP treatment, cells were washed with 
PBS and fresh medium was applied for 30  min in nor-
mal cell culture conditions. Then, cells were washed and 
trypsinized, suspended in cell culture medium containing 
FBS and centrifuged. Cells were suspended in PBS con-
taining 2% FCS and analyzed by Canto II flow cytometer 
(Becton, Dickinson and Company, Franklin Lakes, NJ, 
USA). Green fluorescent cell populations in PLA-NP 
exposed cells, with no inhibitors, were used as positive 
controls, and MFI and percentage changes of these gated 
cells were used for analysis.
Statistical analysis
Concentration of each secreted product was quantified 
with xPONENT software version 4.2 (Biorad Laborato-
ries Inc., Hercules, CA, USA). Flow cytometry analysis 
was performed on BD FACSDiva v8.0. GraphPad Prism 5 
(GraphPad software Inc., La Jolla, CA, USA) was used to 
calculate mean and standard errors of the others assays. 
Normality tests were performed and One-way ANOVA 
and unpaired t test were applied to obtain statistical sig-
nificance of means. Differences were considered statisti-
cally significant at the 0.05 level of confidence.
Results
PLA‑NP characteristics
Micrographs of PLA-NP were acquired by TEM (Fig. 1a). 
Hydrodynamic diameters of PLA-NP in water, assessed 
by DLS, were 63 and 66 nm for non- and green-fluores-
cent PLA-NP, respectively, and zeta potential analysis 
indicated a −49  mV surface charge. Under cell culture 
conditions (without cells), PLA-NPs were shown the 
slightly increase in size compared to samples suspended 
in water, and moreover, a small increase in PLA-NP 
hydrodynamic diameter was observed to be both time- 
and concentration dependent. When incubated at 20 µg/
mL, the z-average hydrodynamic diameter of PLA-
NP was shown to be 78.2  ±  1.5  nm after 1  h incuba-
tion and 82.4 ± 3 nm after 72 h, whereas at 100 µg/mL 
the diameter increased to 102.6 ± 0.4 nm after 1 h and 
104.1 ±  0.9  nm after 72  h, and further increased when 
PLA-NP were incubated at 200 µg/mL, to 111.4 ± 0.5 nm 
after 1 h and 112.6 ± 0.3 nm after 72 h (Fig. 1b). How-
ever, the polydispersity index did not show differences 
over time (1–72 h) indicating a stable particle suspension, 
but was found to reduce dependent upon NP concentra-
tion (20 µg/mL, 0.592 ± 0.03; 100 µg/mL, 0.265 ± 0.01; 
and 200 µg/mL, 0.196 ± 0.01), fluorescent and non-fluo-
rescent PLA-NP were found to be comparable. This data 
suggest that PLA-NP were stable, regarding agglomera-
tion, in cell culture medium up to 72 h.
Effects of PLA‑NP on cell viability, cytotoxicity 
and proliferation
Cell viability, proliferation rates and cytotoxicity 
were assessed after exposure to PLA-NP at different 
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concentrations (2, 20, 100 and 200  µg/mL) for different 
times (6, 24, 48 and 72 h). Determination of MTT con-
version into formazan did not show loss of viability in any 
exposure condition (Fig. 2a). A slight reduction of intra-
cellular ATP level was observed only after 6 h exposure at 
20 µg/mL (9.8 ± 3.9%, p < 0.05), 100 µg/mL (19.1 ± 3.4%, 
p < 0.01) and 200 µg/mL (16.5 ± 3.2%, p < 0.05) (Fig. 2b). 
In addition, LDH release did not increase in response 
to any NP exposure condition compared to control cells 
(Fig. 2c). Analysis of cell proliferation was determined by 
real-time electrical impedance monitoring. PLA-NP did 
not induce alterations in cell proliferation or adhesion 
at the concentrations studied (Fig. 2d). Altogether, these 
data suggest that PLA-NP caused no cytotoxicity, and did 
not induce loss of viability or affect cell proliferation.
Impact of PLA‑NP on cytokine secretion
Multiplex analysis of secreted products from A549 
cells after PLA-NP exposure during 24  h did not show 
increased levels of any soluble mediator, but decreased 
levels of the following mediators were observed: IL-
12p70 at 2, 20 and 200  µg/mL, reducing 28.5  ±  8.2%, 
31.9 ± 9.7% and 33.6 ± 7.3%, respectively, compared to 
control (p < 0.05 for all comparisons). VEGF levels also 
decreased after 24 h, reaching 27.6 ± 10.3%, 32.3 ± 10.6% 
and 28.7 ± 10.8%, for treatments of 2, 20 and 200 µg/mL, 
respectively (p < 0.05 for all comparisons). IL-15 cytokine 
levels were reduced only after 72  h at 200  µg/mL PLA-
NP exposure (37.6 ± 10.3%, p < 0.05). PLA-NP treatment 
did not change the levels of the anti-inflammatory IL-10 
in any condition. The other mediators were unchanged or 
not detected in all conditions (Fig. 3a). The pattern of all 
secreted products after 24, 48 and 72 h of treatment with 
20 µg/mL PLA-NP is shown in the heat map. The positive 
control group induced by TNFα showed increased levels 
of most analyzed mediators (Fig. 3b).
Impact of PLA‑NP on intracellular protein, mRNA, 
and miRNA levels related to cell toxicity, stress 
and inflammation, and apoptosis susceptibility
Proteomic evaluation showed 278 polypeptides were 
either up- or down-regulated in response to 20  µg/mL 
PLA-NP. Amongst these, 145 were completely or partially 
upregulated, including sequences for heat shock proteins 
(HSPs), histones, hemoglobins, heterogeneous nuclear 
ribonucleoproteins and others (Additional file  1: Table 
S1). However, 133 polypeptides were completely or par-
tially downregulated, including actins and actinin subu-
nits, elongation factors, tropomyosin polypeptides and 
others (Additional file  2: Table S2). Biological functions 
of all regulated sequences were determined according to 
GO (Gene Ontology) annotation. Upregulated dominant 
functions comprised of glycolysis, stress response and 
host-virus interaction, whereas downregulated functions 
were related to protein biosynthesis and ‘other’ functions. 
In both differentially regulated groups, proteins were 
detected that have variable or non-described function 
(described as ‘Miscellaneous’ and ‘None’ categories), as 
well as ‘Unclassified’ in terms of their related biological 
processes (Fig. 4a). Major upregulated ‘Unclassified’ pro-
teins were related to nucleic acid, calcium and ATP bind-
ing and structural molecular activity (Additional file  1: 
Table S1). Downregulated ‘Unclassified’ proteins com-
prised of those related to oxidoreductase activity and cal-
cium and ATP binding (Additional file 2: Table S2).
The effects of 20 µg/mL PLA-NP on mRNA expression 
was evaluated after 72 h cell-exposure. The mRNA levels 
of TP53 (tumor suppressor), PCNA (associated with cell 
proliferation) as well as PPARg (involved in inflammation 
pathway) were not altered by PLA-NP (data not shown). 
Moreover, amongst the miRNAs associated with cell 
death and inflammation processes analyzed, only miR155 
was downregulated after PLA-NP exposure (67.1 ± 9.1%, 
p < 0.01) (Fig. 4b).
Since miR155 expression levels were reduced upon 
PLA-NP treatment, and this miRNA is involved with 
cellular resistance in lung epithelial A549 cells [78], it 
was considered that PLA-NP exposure could potentiate 
Fig. 1 PLA‑NP characteristics. a Representative images obtained by 
TEM of 2 μg/mL PLA‑NP. Scale bar 200 nm. b Z‑average hydrodynamic 
diameter values of PLA‑NP at 20, 100 and 200 µg/mL diluted in com‑
plete medium, i.e. same conditions as in cell culture, and analyzed by 
DLS after 1, 6, 24, 48 and 72 h of incubation. Results are expressed as 
mean (±SD)
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Caspases-3/7 activation in response to a agent known to 
induce apoptotic cell death, such as STS. It was shown 
that by pretreating A549 cells with 20 µg/mL PLA-NP for 
72 h, apoptosis in response to 100 nM STS was increased, 
with caspases-3/7 activation increasing by 27.6  ±  4.0% 
(p  <  0.001) compared to control cells (STS-stimulation 
only) (Fig. 4c).
Mechanisms involved in PLA‑NP uptake
Aiming to investigate the mechanisms involved in PLA-
NP uptake, different endocytic pathways were inhibited 
with subtoxic yet according to previous reports still 
functional concentrations of chemicals such as gen-
istein (caveolae), MCD (methyl-β-cyclodextrin) (lipid 
rafts), amiloride (macropinocytosis) and pitstop 2 
(clathrin-coated pits) [4, 8, 28, 35]. Actin staining (red) 
demonstrated that treatments did not affect cell shape 
and adhesion. In order to distinguish between internal-
ized PLA-NP and PLA-NPs situated outside the cells, 
we estimated their position relative to nuclei and actin 
strands by performing confocal Z-stack imaging. Follow-
ing 60  min incubation with 20  µg/mL PLA-NP (green 
dots) it was evident that PLA-NP were internalized 
in all conditions. However, a reduction of their inter-
nalization after inhibiting clathrin-mediated endocy-
tosis was observed (Fig.  5). These conditions were also 
assessed by flow cytometry, where clathrin-mediated 
endocytosis inhibition showed reduction in PLA-NP 
uptake (34.5  ±  4.5%, p  <  0.01) and mean fluorescence 
(26.7  ±  7.8%, p  <  0.05) after 60  min of PLA-NP treat-
ment. When PLA-NP incubation was performed for 
240 min, both inhibition of clathrin-mediated endocyto-
sis and lipid rafts disruption reduced PLA-NP internali-
zation. For clathrin-mediated endocytosis, a reduction of 
Fig. 3 Impact of PLA‑NP on cytokine secretion. a Graphs showing the effects of PLA‑NP at different concentrations (2, 20 and 200 µg/mL) in A549 
cells after 24, 48 and 72 h upon IL‑12p70, VEGF, IL‑15 and IL‑10 levels. b Heat graph showing all secreted products analyzed after 20 µg/mL PLA‑NP 
treatment during 24, 48 and 72 h. ‘+C’ means positive control corresponding to A549 cells treated with 20 ng/mL TNFα for 24 h. Each experimental 
group corresponds to the analysis of three independent experiments. One‑way ANOVA test with Bonferroni’s multiple comparisons test compared 
to respective Control group (*p < 0.05)
(See figure on previous page.) 
Fig. 2 Effects of PLA‑NP on cell viability, cytotoxicity and proliferation. Graphs showing the effects of PLA‑NP at different concentrations (2, 20, 100 
and 200 µg/mL) in A549 cells after 6, 24, 48 and 72 h upon a MTT conversion into formazan, b intracellular ATP levels, and c LDH release compared to 
‘+ Control’. d Real‑time electrical impedance cell monitoring of A549 cells treated with PLA‑NP at different concentrations after 24 h of cell seeding 
and maintained to 96 h. ‘Control’ corresponds to A549 cells without treatment, and ‘+ Control’ means ‘positive control of total LDH release’ treated 
with 1% TX100 for 20 min. Results are expressed as mean (±SD). Each experimental group corresponds to three independent experiments per‑
formed in four replicates. One‑way ANOVA test with Bonferroni’s multiple comparisons test compared to Control group (*p < 0.05, **p < 0.01)
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50.7 ± 12.6% (p < 0.05) (mean fluorescence reduction of 
27 ± 7.1%, p < 0.05) was observed upon inhibition of this 
mechanism, and for lipid rafts inhibition, a 47.3 ± 4.8% 
(p < 0.01) (mean fluorescence reduction of 21.3 ± 4.4%, 
p < 0.01) reduction in uptake was observed. Inhibition of 
caveolae-mediated endocytosis or macropinocytosis did 
not affect PLA-NP uptake in the incubation times per-
formed (Fig. 6a).
As flow cytometry analysis of PLA-NP exposure for 
240  min indicated a reduction of PLA-NP cell uptake 
upon inhibition of lipid raft- and clathrin-mediated endo-
cytosis, these conditions were further assessed by confo-
cal microscopy that confirmed these results (Fig. 6b).
It has previously been demonstrated that treatment 
of cells with MCD, which depletes cholesterol compo-
nents of the cell membrane, can not only influence lipid 
raft mediated uptake, but also clathrin-mediated endo-
cytosis [65]. Therefore, the reduction in PLA-NP uptake 
observed in response to MCD shown here may actually 
infer an association with clathrin-mediated endocyto-
sis (Fig.  5). However, the possibility that lipid rafts may 
be involved in PLA-NP uptake at these longer exposure 
times should not be discarded and deserves careful con-
sideration. We observed co-localization of the endocytic 
cargo (PLA-NP) with ganglioside GM1-bound cholera 
toxin subunit B, which may provide some evidence for 
the involvement of lipid-raft mediated mechanisms. 
(Fig. 6c).
Discussion
Drug delivery systems have been studied extensively 
to improve the efficacy of therapeutic products. Nano-
structured materials attract strong interest for drug 
delivery due to advantages such as increased drug bioa-
vailability and stability, drug targeting leading to a reduc-
tion of required administration dose and thus side effects, 
enhanced delivery of compounds with low water solubil-
ity, among others. Since metallic NP such as Au-NP, the 
most commonly used NP for drug delivery, have shown 
potential to induce cytotoxicity [9, 14, 15, 37], PLA-NP 
emerged as a viable alternative due to their biocompat-
ible and biodegradable characteristics and the poten-
tial to control drug release kinetics [43, 63]. In fact it is 
often Au-NP functionalization which can be implicit in 
the biological responses that they elicit [9, 57]. Therefore, 
this study aimed to perform a detailed evaluation of PLA-
NP induced cell death and stress responses, as well as the 
mechanisms involved in their internalization in human 
lung epithelial cells.
The presented results indicated that PLA-NP were 
stable over time. The observed difference of diameter 
between TEM and DLS may be attributed to the for-
mation of a protein corona due to PLA-NP interaction 
with cell culture medium [34, 45], and/or water shell 
surrounding the NP [25]. As expected, the widely used 
methods for analysis of cell toxicity such as MTT con-
version to formazan, LDH release and intracellular ATP 
levels did not show loss of viability in A549 cells treated 
with PLA-NP. It is important to emphasize that no NP 
interference was observed in these methods. In addition, 
the label-free real-time electrical impedance showed nei-
ther reduced viability nor alterations to cell proliferation, 
in response to PLA-NPs. Altogether, these data are in 
accordance with previous studies showing that PLA-NP 
did not affect the viability of HEK293, CHO-K1, MCF-
7, SK-BR-3 or retinal pigment epithelium cells measured 
(See figure on next page.) 
Fig. 5 Endocytic pathways involved in PLA‑NP uptake. Representative images acquired as Z‑stacks by confocal microscopy of three independent 
experiments. A549 cells were treated with inhibitors for different endocytic pathways followed by 60 min incubation with 20 µg/mL PLA‑NP. On the 
left, the inhibited pathways are indicated, instead of the inhibitors used. Green dots refer to PLA‑NP, red and blue staining to actin and nuclei, respec‑
tively. The mid-lane represents maximum projections of at least 25 optical sections of the Z‑stacks. The images on the right lane are single‑slices from 
the corresponding Z‑stacks and the cross‑hair set indicates evidence of the PLA‑NP internalization (the cross‑section of the sample in the yz‑plane is 
shown on the right and in the xz‑plane at the bottom). Scale bar 30 µm
(See figure on previous page.) 
Fig. 4 Impact of PLA‑NP on intracellular proteins levels and miRNA related to cell toxicity, stress and inflammation. a Percentage of polypeptides 
from proteins into biological functions regulated in response to 20 µg/mL PLA‑NP treatment for 24 h. GO (Gene Ontology) functions are ‘Miscel‑
laneous’ includes proteins with more than 2 biological functions. ‘None’ means none information found. ‘Unclassified’ comprises proteins without 
described biological process but only molecular function. Functions with under 1% percentage were grouped in ‘Others’ category which includes: 
autophagy; bicellular tight junction; blood coagulation and hemostasis; camera‑type eye development/in utero embryonic development; cell 
cycle and mitosis; cell redox homeostasis; differentiation; neurogenesis; ectoderm development; mineral balance; N‑glycan processing; nucleotide 
metabolism; pyridoxal 5′‑phosphate salvage. b miRNA analysis of A549 cells exposed to 20 µg/mL PLA‑NP after 72 h incubation. Each experimental 
group corresponds to three independent experiments. Student t‑test compared to Control group (**p < 0.01). c Apoptosis susceptibility of A549 
cells exposed to 20 µg/mL PLA‑NP during 72 h followed by 24 h treatment with 100 nM STS. Each experimental group corresponds to the analysis of 
three independent experiments performed in duplicates. Student t test compared to STS group (***p < 0.001). Results are expressed as mean (±SEM)
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through the analysis of formazan reaction products [6, 7, 
43, 46].
Notably, this study shows that IL-12 and VEGF levels 
were reduced upon 24 h PLA-NP exposure, returning to 
background levels by 48 h. IL-12 is related to inhibition 
of lung adenocarcinoma cell migration and invasion [39] 
and protective immunity against lung infection mediated 
by methicillin-resistant Staphylococcus aureus (MRSA), 
Fig. 6 Flow cytometry and confocal analysis of PLA‑NP uptake. a Flow cytometry analysis of A549 cells treated with the endocytic pathways inhibi‑
tors followed by 60 or 240 min incubation with 20 µg/mL PLA‑NP. ‘P3 Gate’ refers to A549 half population in green fluorescent gate region. ‘Mean 
Fluorescence’ reflects the analysis of ‘P3 Gate’. Each experimental group corresponds to three independent experiments performed in two replicates. 
Student t test compared the experimental condition to respective Control groups (*p < 0.05, **p < 0.01). Results are expressed as mean (±SEM). b 
Representative images of three independent experiments acquired by confocal microscopy of A549 cells treated with lipid rafts and clathrin pits 
inhibitors followed by 240 min incubation with 20 µg/mL PLA‑NP. Green dots refers to PLA‑NP, red and blue staining to actin and nuclei, respectively. 
c Representative images of three independent experiments showing the co‑localization of the lipid raft marker CTX‑Alexa Fluor 594 and PLA‑NP in 
A549 cells. Green dots refer to PLA‑NP, red and blue staining to ganglioside GM1‑bound CTX and nuclei, respectively. Cross‑hair lines in the Z‑stack 
images evidence green and red fluorescence overlapping, hence co‑localization. Scale bar 30 µm
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a common pathogen related to pneumonia [49]. Despite 
data demonstrating that PLA-NP did not affect A549 cell 
viability and proliferation, reduced levels of IL-12 dur-
ing 24 h exposures suggest that the use of PLA-NP as a 
nanocarrier may contribute to increased vulnerability of 
lung epithelial cells to opportunistic infections. Regard-
ing VEGF, it is involved with angiogenesis, growth and 
proliferation of lung epithelial cells through autocrine 
mechanisms, as well as in tissue repair and survival 
[27, 30, 48]. In addition, reduced levels of VEGF result 
in increased markers of oxidative stress and structural 
alterations of alveoli [72], being implicated in the patho-
genesis of restrictive and obstructive lung diseases such 
as emphysema [74]. Nevertheless, it is conceivable that 
the transient reduction of IL-12 and VEGF levels induced 
by PLA-NP may not impact on lung epithelial cell func-
tion. Moreover, other studies have shown that A549 cells 
produce pro-inflammatory cytokines upon NP exposure. 
Titanium dioxide NP increased IL-2, IL-6, IFN-γ and 
TNF-α levels [44], while silver NP increased TNF-α levels 
[32]. In contrast, our results exposing A549 cells to PLA-
NP did not induce these cytokines, reinforcing the bio-
compatibility of PLA-NP in A549 cells.
Proteomics data showed that expression of different 
HSPs, which are involved in stress responses and virus 
interaction, were prominently increased, more so than 
other proteins. HSPs are highly conserved molecular 
chaperones displaying key roles in signal transduction, 
protein folding and degradation. HSP90 is involved in 
the folding, assembly, maturation and stabilization of 
proteins, important to survival and proliferation [19]. 
Members of the HSP90 family were upregulated in our 
analysis, including HSP90B2P, GRP94c and tumor rejec-
tion antigen Gp96 (TRA1). Studies have suggested that 
GRP94 upregulation occurs under hypoxia [55], and is 
involved in apoptosis when homeostasis of endoplasmic 
reticulum is disrupted [31]. In the context of endoplas-
mic reticulum stress, upregulation of hsp gene expression 
upon Au-NP exposure has previously been reported in C. 
elegans and a protective role for these gene products has 
been postulated [71].
Here, HSP70 and HSP60 chaperonin members 
(HSPA1A; HSPA5; HSPA6; HSPA8; HSPD1) were upreg-
ulated in A549 cells in response to PLA-NP. Studies 
have shown that HSPA1A and HSPA5 display protec-
tive properties to stress conditions, amyloid polypeptide 
aggregation and toxicity and apoptosis [58]. The expres-
sion of HSP70, HSP90, GRP78, and GRP94 is increased 
along hepatocarcinogenesis progression. GRP78 and 
GRP94 are related to vascular invasion and intrahepatic 
metastasis [40]. Moreover, HSPA8 and HSPD1 chaper-
onins are related to host-virus interaction in biological 
processes. HSPA8 mediates an LPS-induced inflamma-
tory response, including TNF-α secretion by monocytes 
[70]. HSPD1 is able to interact with interferon regulatory 
factor 3 (IRF3) contributing to IFN-β signaling during 
Sendai virus infection [41].
The potential role of HSP22, HSP60, HSP70, and 
HSP72 to act as danger-associated molecular patterns 
(DAMPs) in pro-inflammatory responses leading to 
activation of innate immune cells including neutrophils, 
macrophages, monocytes, and dendritic cells through 
their interaction with Toll-like receptors (TLRs)-2 and 
-4, has been extensively investigated [3, 13]. Hence, the 
increased expression of HSPs in response to PLA-NP 
may infer promotion of cell survival mechanisms, in 
which the stress responses observed within the cells’ 
proteome occurred in the absence of cell death or loss 
of cell viability, as demonstrated in the assays based on 
metabolic activity (MTT, ATP) and membrane integrity 
(LDH). One limitation of the proteomic results described 
here is that only a single exposure condition (one NP 
concentration and time point) was tested, therefore, this 
preliminary data on a potential upregulation of HSPs 
upon PLA-NP treatment require further validation cov-
ering a more comprehensive range of time points and NP 
concentrations.
Due to the absence of cytotoxicity, while alterations 
to intracellular proteins involved in cell functions was 
evident, we investigated whether PLA-NP could trig-
ger gene alterations related to inflammation and cell 
death processes, through determination of mRNA and 
miRNA. While no change was observed for mRNA, 
miR155 was strongly reduced. Distinct expression pro-
files of miR155 seem to play a role in both physiological 
and pathological processes such as immunity, inflamma-
tion, hematopoiesis, and cardiovascular and neoplastic 
diseases [21]. Indeed, some miRNAs, including miR155, 
are increased in human lung cancer and it has been sug-
gested as a biomarker of poor prognosis in lung cancer 
patients [59, 76]. The tumor suppressor TP53 mRNA is 
a potential miR155 target. However, in the present study, 
the expression levels of TP53 mRNA were evaluated and 
no changes were observed when comparing PLA-treated 
with untreated cells. Moreover, a study using A549 cells 
demonstrated that miR155 negatively regulates Apaf-
1, a protein involved in apoptotic mechanisms, confer-
ring cellular resistance to cisplatin treatment [78]. In 
this sense, this study evaluated whether reduced miR155 
expression levels induced by PLA-NP could confer sus-
ceptibility to death stimuli in A549 cells. This hypothesis 
was reinforced by an increase in susceptibility of A549 
cells to STS-induced cell death, when pre-stimulated 
with PLA-NP. In the context of lung infection, PLA-NP 
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may influence inflammatory responses and increase cell 
death. Our hypothesis is supported by a study showing 
that previous acute exposure to silica NP increased the 
susceptibility of mice to lethal pneumonia induced by 
Pseudomonas aeruginosa [16]. Such results suggest that 
chronic use of PLA-NP requires attention to these mark-
ers (Fig. 7).
The endocytic mechanisms related to PLA-NP 
uptake in A549 cells were also investigated. The results 
showed that such NP are internalized mostly by clath-
rin-mediated endocytosis or in association with lipid 
rafts. PLA-NP endocytosis mediated by clathrin-coated 
pits occurred within 60  min, where the major levels of 
internalization may be attributed to a quick mechanism 
ranging from ~45 to ~80 s. This involves different stages 
such as initiation, growth, stabilization and pit com-
mitment cargo capture, budding and scission, and 
finally uncoating [33]. Previously, it was suggested that 
poly(lactic-co-glycolic acid) NP (PLGA-NP) and solid 
lipid NP uptake occurred mainly through a clathrin-
dependent manner in lung epithelial A549 cells, using 
hypertonic sucrose medium [61, 67, 68]. However, it is 
well known that hypertonic sucrose medium also inhibits 
the uptake of cholera toxin, a lipid raft ligand [12]. More-
over, hypertonic sucrose medium inhibits endocytosis 
mediated by pinocytosis [10, 66]. These studies strongly 
support that the use of hypertonic sucrose medium is 
not selective to inhibit clathrin-coated pits. In this sense, 
Fig. 7 Schematic representation of PLA‑NP internalization through clathrin‑coated pits and lipid rafts in cell membrane. Endocytosis mediated 
by clathrin‑coated pits is a fast and dynamic mechanism beginning with membrane invagination. This process involves different stages such as 
initiation, growth, stabilization and pit commitment, cargo capture, budding, scission and uncoating, during ~45 to ~80 s. This mechanism is 
dependent on proteins such as clathrin and dynamin. The diameter of coated vesicles vary from ~70 to ~135 nm, according to cell type [33]. Lipid 
rafts are microdomains enriched in cholesterol and sphingolipids such as sphingomyelin. Such membrane specialization is a less fluid region that 
compartmentalizes proteins related to intracellular signaling pathways. Planar lipid rafts can be associated to flotillins mediating endocytosis in 
a clathrin‑ and caveolin‑independent manner by a still unknown mechanism [47]. In this work, we observed that PLA‑NP uptake was mediated 
preponderantly by clathrin‑coated pits and lipid rafts in A549 cells. Despite the non‑alteration in cell viability, PLA‑NP promoted modifications in 
biological functions that may affect cell physiology. IL‑12 and VEGF secretion and miR155 levels were reduced while intracellular HSPs levels were 
increased. Such alterations may contribute to increased susceptibility to cell death
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lipid rafts could also be involved in NP uptake. In the 
present work, a competitive inhibitor of clathrin termi-
nal domains was used, which selectively inhibits clathrin-
mediated endocytosis. Thus, it was possible to infer that 
clathrin pits are involved in PLA-NP uptake in lung epi-
thelial A549 cells (Fig. 7).
The endocytosis of PLA-NP mediated by lipid rafts 
was observed after 240 min exposure through cholesterol 
depletion. However, clathrin- and caveolae-mediated 
endocytosis can also be sensitive to cholesterol deple-
tion [11, 65, 79]. In this respect, it is possible that the late 
effect we observed in response to MCD may be attributed 
to inhibition of clathrin pits. However, the intracellular 
co-localization of PLA-NP and ganglioside M1 prompted 
us to infer that PLA-NP are taken up also through lipid 
rafts. In fact, studies have demonstrated that planar lipid 
rafts can be associated to flotillins mediating endocytosis 
in a clathrin- and caveolin-independent manner [23, 26, 
53]. No involvement of caveolae-mediated uptake mech-
anisms was considered in the PLA-NP used in this study.
Previous studies have shown that the majority of NP 
administrated through inhalation are phagocytized by 
alveolar macrophages [24, 64]. Upon internalization of 
PLA-NP, lysosomes are considered as their intracellular 
fate [5]. Moreover, it is important to emphasize that the 
uptake mechanisms are also dependent on physicochem-
ical properties of the NP, such as material composition, 
size, shape and others, as well as the cell type investi-
gated, as has been reviewed recently [62]. In the present 
study, PLA-NP internalization in A549 cells mediated by 
clathrin-coated pits appeared to be dominant over other 
endocytic pathways in initial cell contact, but lipid rafts 
display relevant involvement in extended periods of PLA-
NP incubation. These results may help to improve strat-
egies aiming for selective nanocarrier uptake through 
proteins/biomarkers located in membrane structures 
involved in endocytosis.
Conclusions
Using high-throughput screening methods and more 
complex methodologies, we have demonstrated that 
the biodegradable PLA-NP induced alterations to the 
proteome of the A549 lung epithelial cell line. PLA-NP 
strongly increased HSPs proteins related to cell stress and 
decreased the secretion of soluble mediators and miR155 
levels. Such critical modifications in cell physiology may 
indicate increased susceptibility to apoptosis. Moreover, 
PLA-NP uptake was mostly by clathrin-dependent mech-
anisms with lipid raft involvement during long periods 
of incubation. These data can contribute to the develop-
ment of safe-by-design nanocarriers and to the improve-
ment of selective uptake strategies.
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